$CLFD
Clearfield, Inc.

2018 Q1 Form 10-Q Financial Statement

#000117184318003305 Filed on May 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $16.83M $17.65M
YoY Change -4.65% 4.16%
Cost Of Revenue $10.05M $10.21M
YoY Change -1.55% 5.61%
Gross Profit $6.780M $7.443M
YoY Change -8.91% 2.23%
Gross Profit Margin 40.28% 42.16%
Selling, General & Admin $7.306M $6.162M
YoY Change 18.56% 19.96%
% of Gross Profit 107.75% 82.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $550.0K $410.0K
YoY Change 34.15% 13.89%
% of Gross Profit 8.11% 5.51%
Operating Expenses $7.306M $6.162M
YoY Change 18.56% 19.96%
Operating Profit -$525.8K $1.281M
YoY Change -141.05% -40.25%
Interest Expense $120.0K $60.00K
YoY Change 100.0% 50.0%
% of Operating Profit 4.69%
Other Income/Expense, Net
YoY Change
Pretax Income -$406.4K $1.341M
YoY Change -130.31% -38.58%
Income Tax -$101.0K $433.0K
% Of Pretax Income 32.3%
Net Earnings -$305.4K $907.5K
YoY Change -133.65% -39.21%
Net Earnings / Revenue -1.81% 5.14%
Basic Earnings Per Share -$0.02 $0.07
Diluted Earnings Per Share -$0.02 $0.07
COMMON SHARES
Basic Shares Outstanding 13.45M 13.59M
Diluted Shares Outstanding 13.45M 13.80M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.40M $28.30M
YoY Change -45.58% -2.08%
Cash & Equivalents $9.141M $22.48M
Short-Term Investments $6.300M $5.800M
Other Short-Term Assets $1.070M $975.0K
YoY Change 9.69% 67.47%
Inventory $10.88M $9.971M
Prepaid Expenses
Receivables $7.159M $8.114M
Other Receivables $0.00 $0.00
Total Short-Term Assets $34.53M $47.36M
YoY Change -27.08% 4.12%
LONG-TERM ASSETS
Property, Plant & Equipment $5.054M $6.025M
YoY Change -16.12% 12.04%
Goodwill $4.709M $2.571M
YoY Change 83.17% 0.0%
Intangibles $5.618M
YoY Change
Long-Term Investments $20.20M $15.00M
YoY Change 34.67% 92.31%
Other Assets $228.8K $438.7K
YoY Change -47.84% 25.07%
Total Long-Term Assets $35.79M $24.05M
YoY Change 48.82% 49.54%
TOTAL ASSETS
Total Short-Term Assets $34.53M $47.36M
Total Long-Term Assets $35.79M $24.05M
Total Assets $70.32M $71.41M
YoY Change -1.51% 15.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.799M $2.361M
YoY Change -23.83% -25.16%
Accrued Expenses $31.44K $54.79K
YoY Change -42.62% 3.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.934M $5.044M
YoY Change -22.0% -12.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $300.0K $200.0K
YoY Change 50.0% 0.0%
Total Long-Term Liabilities $336.9K $660.7K
YoY Change -49.01% -2.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.934M $5.044M
Total Long-Term Liabilities $336.9K $660.7K
Total Liabilities $4.271M $5.705M
YoY Change -25.13% -11.1%
SHAREHOLDERS EQUITY
Retained Earnings $9.618M $6.917M
YoY Change 39.05% -459.54%
Common Stock $138.1K $141.4K
YoY Change -2.35% 3.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.05M $65.70M
YoY Change
Total Liabilities & Shareholders Equity $70.32M $71.41M
YoY Change -1.51% 15.98%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$305.4K $907.5K
YoY Change -133.65% -39.21%
Depreciation, Depletion And Amortization $550.0K $410.0K
YoY Change 34.15% 13.89%
Cash From Operating Activities $260.0K $600.0K
YoY Change -56.67% -22.08%
INVESTING ACTIVITIES
Capital Expenditures -$290.0K -$530.0K
YoY Change -45.28% 178.95%
Acquisitions
YoY Change
Other Investing Activities -$11.07M $390.0K
YoY Change -2938.46% -159.09%
Cash From Investing Activities -$11.36M -$150.0K
YoY Change 7473.33% -82.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -210.0K -20.00K
YoY Change 950.0% -66.67%
NET CHANGE
Cash From Operating Activities 260.0K 600.0K
Cash From Investing Activities -11.36M -150.0K
Cash From Financing Activities -210.0K -20.00K
Net Change In Cash -11.31M 430.0K
YoY Change -2730.23% -386.67%
FREE CASH FLOW
Cash From Operating Activities $260.0K $600.0K
Capital Expenditures -$290.0K -$530.0K
Free Cash Flow $550.0K $1.130M
YoY Change -51.33% 17.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
30735591
CY2017Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
22916463
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
5782
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
34268
clfd Number Of Patents Granted
NumberOfPatentsGranted
12
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1798776
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1739791
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7159376
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7237641
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31441
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
93304
CY2018Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2103906
CY2017Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2410026
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56296908
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55406888
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
485794
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
969081
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
590165
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1183911
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79085
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79085
CY2018Q1 us-gaap Assets
Assets
70323901
CY2017Q3 us-gaap Assets
Assets
69494037
CY2018Q1 us-gaap Assets Current
AssetsCurrent
34534451
CY2017Q3 us-gaap Assets Current
AssetsCurrent
41143402
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Basis of Presentation</div></div> <div style=" margin: 0pt 0; font-size: 10pt">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; color: black">The accompanying (a) condensed balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>which has been derived from audited financial statements, and (b) unaudited interim condensed financial statements as of and for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018 </div>have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to these rules and regulations, certain financial information and footnote disclosures normally included in the financial statements have been condensed or omitted. However, in the opinion of management, the financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the financial position and results of operations and cash flows of the interim periods presented. </div>Operating results for the interim periods presented are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of results to be expected for the full year or for any other interim period, due to variability in customer purchasing patterns and seasonal, operating and other factors. <div style="display: inline; color: black">These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017.</div></div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In preparation of the Company&#x2019;s financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses during the reporting periods. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">Certain comparative figures have been reclassified to conform to the current period's presentation. These reclassifications did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> affect the prior periods' net income, shareholders&#x2019; equity, or cash flows.</div></div>
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9141197
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18536111
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28014321
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22483013
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9394914
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5531308
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13811076
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13812821
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13811076
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13812821
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
138111
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
138128
CY2018Q1 us-gaap Goodwill
Goodwill
4708511
CY2017Q3 us-gaap Goodwill
Goodwill
2570511
us-gaap Cost Of Revenue
CostOfRevenue
19809538
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.323
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3999219
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P6Y219D
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
10051061
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
10208957
us-gaap Cost Of Revenue
CostOfRevenue
21266399
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-384000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2018Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
276797
CY2017Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
281720
CY2018Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
60076
CY2017Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
444076
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
989912
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800136
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.249
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.911
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1594
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5100
CY2017Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018Q1 us-gaap Gross Profit
GrossProfit
6779834
CY2017Q1 us-gaap Gross Profit
GrossProfit
7442814
us-gaap Gross Profit
GrossProfit
13888241
us-gaap Gross Profit
GrossProfit
14651534
CY2018Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
26465225
CY2017Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
25753150
CY2018Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
20180000
CY2017Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
19816000
CY2018Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
6285225
CY2017Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
5937150
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-406376
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1340521
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
333782
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2584451
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-101000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-304000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
433000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-384000
us-gaap Income Taxes Paid
IncomeTaxesPaid
23987
us-gaap Income Taxes Paid
IncomeTaxesPaid
416750
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-313921
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2296544
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-78265
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
115011
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-354984
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1597722
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
71117
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-234201
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5618260
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
284787
CY2018Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4673999
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1737456
CY2018Q1 us-gaap Inventory Net
InventoryNet
10879149
CY2017Q3 us-gaap Inventory Net
InventoryNet
8453567
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
245165
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
236024
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
49352
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9262
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10326
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
10350000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4181075
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10166075
CY2018Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
5399534
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5991863
CY2018Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
805616
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
724248
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
119379
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
59885
us-gaap Investment Income Interest
InvestmentIncomeInterest
215101
us-gaap Investment Income Interest
InvestmentIncomeInterest
112619
CY2018Q1 us-gaap Liabilities
Liabilities
4270996
CY2017Q3 us-gaap Liabilities
Liabilities
4968917
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70323901
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69494037
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3934123
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4243121
CY2018Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
336873
CY2017Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
725796
CY2018Q1 us-gaap Long Term Investments
LongTermInvestments
20180000
CY2017Q3 us-gaap Long Term Investments
LongTermInvestments
19816000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-79078
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138281
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11578416
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5657911
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2262580
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11678
us-gaap Net Income Loss
NetIncomeLoss
637782
us-gaap Net Income Loss
NetIncomeLoss
1784451
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-305376
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
907521
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-525755
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1280636
us-gaap Operating Income Loss
OperatingIncomeLoss
118681
us-gaap Operating Income Loss
OperatingIncomeLoss
2471832
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1069504
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
978933
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
228820
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
516341
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1064936
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
339012
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
38950
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6162178
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13769560
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12179702
us-gaap Share Based Compensation
ShareBasedCompensation
969081
us-gaap Share Based Compensation
ShareBasedCompensation
1183911
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
148259
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
169500
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
3469000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
5568000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5100
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17949
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28459
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5053859
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5434172
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9617886
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8980104
CY2018Q1 us-gaap Revenues
Revenues
16830895
CY2017Q1 us-gaap Revenues
Revenues
17651771
us-gaap Revenues
Revenues
33697779
us-gaap Revenues
Revenues
35917933
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7305589
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32850
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.79
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.58
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y146D
CY2018Q1 us-gaap Short Term Investments
ShortTermInvestments
6285225
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
66052905
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
64525120
CY2017Q3 us-gaap Short Term Investments
ShortTermInvestments
5937150
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15750
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6100
CY2018Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
214588
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
47255
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
218948
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13450482
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13803697
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13494433
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13797126
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13450482
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13589109
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13447178
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13578178

Files In Submission

Name View Source Status
0001171843-18-003305-index-headers.html Edgar Link pending
0001171843-18-003305-index.html Edgar Link pending
0001171843-18-003305.txt Edgar Link pending
0001171843-18-003305-xbrl.zip Edgar Link pending
clfd-20180331.xml Edgar Link completed
clfd-20180331.xsd Edgar Link pending
clfd-20180331_cal.xml Edgar Link unprocessable
clfd-20180331_def.xml Edgar Link unprocessable
clfd-20180331_lab.xml Edgar Link unprocessable
clfd-20180331_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_050218p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending